Skip to content

XLV vs. DFAC: What’s The Difference?

The Health Care Select Sector SPDR Fund (XLV) and the Dimensional U.S. Core Equity 2 ETF (DFAC) are both among the Top 100 ETFs. XLV is a SPDR State Street Global Advisors Health fund and DFAC is a Dimensional Fund Advisors Large Blend fund. So, what’s the difference between XLV and DFAC? And which fund is better?

The expense ratio of XLV is 0.07 percentage points lower than DFAC’s (0.12% vs. 0.19%). XLV also has a higher exposure to the healthcare sector and a lower standard deviation. Overall, XLV has provided higher returns than DFAC over the past ten years.

In this article, we’ll compare XLV vs. DFAC. We’ll look at risk metrics and holdings, as well as at their performance and portfolio growth. Moreover, I’ll also discuss XLV’s and DFAC’s fund composition, annual returns, and industry exposure and examine how these affect their overall returns.

DivX VS Xvid: What’s The Differen...
DivX VS Xvid: What’s The Difference?
TIP: Keep track of all your investments with Personal Capital. I use this amazing tool to aggregate all investments in one place and make sure I'm on track to financial freedom. Oh, and did I mention it's free? Try it out here (link to Personal Capital).

Summary

XLVDFAC
NameHealth Care Select Sector SPDR FundDimensional U.S. Core Equity 2 ETF
CategoryHealthLarge Blend
IssuerSPDR State Street Global AdvisorsDimensional Fund Advisors
AUM27.88B13.53B
Avg. Return15.02%13.93%
Div. Yield1.4%1.0%
Expense Ratio0.12%0.19%

The Health Care Select Sector SPDR Fund (XLV) is a Health fund that is issued by SPDR State Street Global Advisors. It currently has 27.88B total assets under management and has yielded an average annual return of 15.02% over the past 10 years. The fund has a dividend yield of 1.4% with an expense ratio of 0.12%.

The Dimensional U.S. Core Equity 2 ETF (DFAC) is a Large Blend fund that is issued by Dimensional Fund Advisors. It currently has 13.53B total assets under management and has yielded an average annual return of 13.93% over the past 10 years. The fund has a dividend yield of 1.0% with an expense ratio of 0.19%.

XLV’s dividend yield is 0.40% higher than that of DFAC (1.4% vs. 1.0%). Also, XLV yielded on average 1.09% more per year over the past decade (15.02% vs. 13.93%). The expense ratio of XLV is 0.07 percentage points lower than DFAC’s (0.12% vs. 0.19%).

FYI: The best way I've found to invest in ETFs is through M1 Finance. It's free and you even get an instant line of credit! Have a look here (link to M1 Finance).

Fund Composition

Industry Exposure

XLV vs. DFAC - Industry Exposure

XLVDFAC
Technology0.0%22.81%
Industrials0.0%14.13%
Energy0.0%2.67%
Communication Services0.0%7.63%
Utilities0.0%1.54%
Healthcare100.0%12.09%
Consumer Defensive0.0%5.94%
Real Estate0.0%0.37%
Financial Services0.0%16.17%
Consumer Cyclical0.0%13.09%
Basic Materials0.0%3.56%

The Health Care Select Sector SPDR Fund (XLV) has the most exposure to the Healthcare sector at 100.0%. This is followed by Technology and Industrials at 0.0% and 0.0% respectively. Consumer Cyclical (0.0%), Financial Services (0.0%), and Real Estate (0.0%) only make up 0.00% of the fund’s total assets.

XLV’s mid-section with moderate exposure is comprised of Consumer Defensive, Utilities, Communication Services, Energy, and Industrials stocks at 0.0%, 0.0%, 0.0%, 0.0%, and 0.0%.

The Dimensional U.S. Core Equity 2 ETF (DFAC) has the most exposure to the Technology sector at 22.81%. This is followed by Financial Services and Industrials at 16.17% and 14.13% respectively. Utilities (1.54%), Energy (2.67%), and Basic Materials (3.56%) only make up 7.77% of the fund’s total assets.

DFAC’s mid-section with moderate exposure is comprised of Consumer Defensive, Communication Services, Healthcare, Consumer Cyclical, and Industrials stocks at 5.94%, 7.63%, 12.09%, 13.09%, and 14.13%.

XLV is 87.91% more exposed to the Healthcare sector than DFAC (100.0% vs 12.09%). XLV’s exposure to Technology and Industrials stocks is 22.81% lower and 14.13% lower respectively (0.0% vs. 22.81% and 0.0% vs. 14.13%). In total, Consumer Cyclical, Financial Services, and Real Estate also make up 29.63% less of the fund’s holdings compared to DFAC (0.00% vs. 29.63%).

Holdings

XLV - Holdings

XLV HoldingsWeight
Johnson & Johnson9.19%
UnitedHealth Group Inc8.01%
Pfizer Inc4.64%
Abbott Laboratories4.36%
AbbVie Inc4.21%
Thermo Fisher Scientific Inc4.2%
Merck & Co Inc4.17%
Eli Lilly and Co3.87%
Danaher Corp3.61%
Medtronic PLC3.54%

XLV’s Top Holdings are Johnson & Johnson, UnitedHealth Group Inc, Pfizer Inc, Abbott Laboratories, and AbbVie Inc at 9.19%, 8.01%, 4.64%, 4.36%, and 4.21%.

Thermo Fisher Scientific Inc (4.2%), Merck & Co Inc (4.17%), and Eli Lilly and Co (3.87%) have a slightly smaller but still significant weight. Danaher Corp and Medtronic PLC are also represented in the XLV’s holdings at 3.61% and 3.54%.

DFAC - Holdings

DFAC HoldingsWeight
Apple Inc4.7%
Microsoft Corp3.81%
Amazon.com Inc2.39%
Johnson & Johnson1.05%
Facebook Inc Class A1.05%
JPMorgan Chase & Co1.0%
Alphabet Inc Class C0.85%
Alphabet Inc Class A0.84%
Berkshire Hathaway Inc Class B0.75%
Visa Inc Class A0.74%

DFAC’s Top Holdings are Apple Inc, Microsoft Corp, Amazon.com Inc, Johnson & Johnson, and Facebook Inc Class A at 4.7%, 3.81%, 2.39%, 1.05%, and 1.05%.

JPMorgan Chase & Co (1.0%), Alphabet Inc Class C (0.85%), and Alphabet Inc Class A (0.84%) have a slightly smaller but still significant weight. Berkshire Hathaway Inc Class B and Visa Inc Class A are also represented in the DFAC’s holdings at 0.75% and 0.74%.

NOTE: The easiest way to add diversification to your portfolio is to invest in real estate through Fundrise. You can become private real estate investor without the burden of property management! Check it out here (link to Fundrise).

Risk Analysis

XLVDFAC
Mean Return1.271.19
R-squared58.1995.1
Std. Deviation12.9415.55
Alpha7.75-2.75
Beta0.71.12
Sharpe Ratio1.130.88
Treynor Ratio21.111.85

The Health Care Select Sector SPDR Fund (XLV) has a Standard Deviation of 12.94 with a Beta of 0.7 and a Sharpe Ratio of 1.13. Its Alpha is 7.75 while XLV’s Treynor Ratio is 21.1. Furthermore, the fund has a Mean Return of 1.27 and a R-squared of 58.19.

The Dimensional U.S. Core Equity 2 ETF (DFAC) has a Treynor Ratio of 11.85 with a Standard Deviation of 15.55 and a R-squared of 95.1. Its Sharpe Ratio is 0.88 while DFAC’s Beta is 1.12. Furthermore, the fund has a Mean Return of 1.19 and a Alpha of -2.75.

XLV’s Mean Return is 0.08 points higher than that of DFAC and its R-squared is 36.91 points lower. With a Standard Deviation of 12.94, XLV is slightly less volatile than DFAC. The Alpha and Beta of XLV are 10.50 points higher and 0.42 points lower than DFAC’s Alpha and Beta.

FYI: Another great way to get exposure to the real estate sector is by investing in real estate debt. Groundfloor offers fantastic short-term, high-yield bonds that can add diversification to your portfolio!

Performance

Annual Returns

XLV vs. DFAC - Annual Returns

YearXLVDFAC
202013.33%15.8%
201920.63%29.54%
20186.3%-9.43%
201721.7%18.82%
2016-2.83%16.31%
20156.82%-2.53%
201425.17%9.56%
201341.24%37.55%
201217.56%17.93%
201112.44%-1.96%
20102.91%21.67%

XLV had its best year in 2013 with an annual return of 41.24%. XLV’s worst year over the past decade yielded -2.83% and occurred in 2016. In most years the Health Care Select Sector SPDR Fund provided moderate returns such as in 2011, 2020, and 2012 where annual returns amounted to 12.44%, 13.33%, and 17.56% respectively.

The year 2013 was the strongest year for DFAC, returning 37.55% on an annual basis. The poorest year for DFAC in the last ten years was 2018, with a yield of -9.43%. Most years the Dimensional U.S. Core Equity 2 ETF has given investors modest returns, such as in 2020, 2016, and 2012, when gains were 15.8%, 16.31%, and 17.93% respectively.

Portfolio Growth

XLV vs. DFAC - Portfolio Growth

FundInitial BalanceFinal BalanceCAGR
XLV$10,000$44,14715.02%
DFAC$10,000$38,79613.93%

A $10,000 investment in XLV would have resulted in a final balance of $44,147. This is a profit of $34,147 over 11 years and amounts to a compound annual growth rate (CAGR) of 15.02%.

With a $10,000 investment in DFAC, the end total would have been $38,796. This equates to a $28,796 profit over 11 years and a compound annual growth rate (CAGR) of 13.93%.

XLV’s CAGR is 1.09 percentage points higher than that of DFAC and as a result, would have yielded $5,351 more on a $10,000 investment. Thus, XLV outperformed DFAC by 1.09% annually.


Current recommendations:

Over the past years, I have discovered several tools and products that have helped me tremendously on my path to financial freedom:

P.S.: The links below are affiliate links, which means I receive a small commission at no extra cost to you when you sign up for one of the services. Thank you for your support!

1)Personal Capital is simply the best tool out there to track your net worth and plan for financial freedom. Just their retirement planner alone has become an invaluable tool to keep myself on track financially. Try it out, it's free!

2) Take a look at M1 Finance, my favorite broker. I love how easy it is to invest and maintain my portfolio with them. I can set up automatic transfers, rebalance my portfolio with one click and even borrow up to 35% of my assets at super low interest rates!

3) Fundrise is by far the best way I've found to invest in Real Estate. You can diversify your portfolio by investing in their eREITs or even allocate capital to individual properties (without the hassle of managing tenants!).

4) Groundfloor is another great way to get exposure to the real estate sector by investing in short-term, high-yield real estate debt. Current returns are >10% and you can get started with just $10.

5) If you are interested in startup investing, check out Mainvest. I've started allocating a small amount of assets to invest in and support small businesses. Return targets are between 10-25% and you can start with just $100!

To see all of my most up-to-date recommendations, check out the Recommended Tools section.

Leave a Reply

Your email address will not be published.